Europe Clinical Reference Laboratory Market Forecast to 2031

Europe Clinical Reference Laboratory Market Forecast to 2031 – Regional Analysis – by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)

Send Enquiry

$2,485$3,885

Description

The Europe clinical reference laboratory market was valued at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031; it is estimated to register a CAGR of 6.2% from 2023 to 2031.

Increasing Number of Clinical Trials Drives Europe Clinical Reference Laboratory Market

Clinical trials assist in evaluating whether a new treatment or prevention method, such as a new medicine, diet, or medical technology, is safe and effective. The trials are primarily conducted during the drug development phase. According to the European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are approved annually, with the pharmaceutical industry accounting for roughly 60%. Due to the growing prevalence of chronic diseases, the number of clinical trials is increasing to develop various effective treatments. Clinical trials are gradually becoming complex procedures, because proper execution and oversight of the operations occurring in research-based organizations have become crucial. Research-based organizations are outsourcing clinical trials while developing their products to avoid errors due to improper execution. Reference laboratories are well-known for their proactive approach to keeping up with scientific and technological advancements. Reference labs promptly adopt and integrate new diagnostic instruments, equipment, and techniques, allowing them to evaluate their potential applications and benefits. Clinical reference labs help research teams successfully conduct their projects by providing a comprehensive menu of clinical and comparative testing performed inexpensively and efficiently. Clinical reference labs collect and provide the required samples and perform the necessary testing at their facility. That means all the services are available under one roof. Vimta Labs Ltd, Regional Pathology Services, and Boca Bio provide commercial clinical trial services. Thus, the increasing number of clinical trials is driving the clinical reference laboratory market growth.

Europe Clinical Reference Laboratory Market Overview

Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany’s well-established transport, communication, energy, and public services infrastructure. According to an article published by the National Institutes of Health in December 2023, ~4 million people had a rare disease in Germany. Rare diseases have complex clinical patterns. Treatments for such diseases need accelerated trials and fast-track clinical outcomes. This is where reference laboratories play a crucial role. In January 2023, Premier Research partnered with CENTOGENE to de-risk rare disease clinical development. Premier Research’s extensive expertise in rare disease product development will be supported by advanced insights generated by the CENTOGENE Biodatabank and multiomic reference laboratories. Moreover, the demand for anti-infective agents in Germany is growing significantly, attributed to the increasing prevalence of chronic viral diseases and the growing demand to produce new molecules for viral therapeutic areas to fulfill unmet conditions. The market is expected to grow significantly in the country due to the abovementioned factors.

Europe Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million)

Europe Clinical Reference Laboratory Market Segmentation

The Europe clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the Europe clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the Europe clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the Europe clinical reference laboratory market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, UNILABS, Laboratory Corp of America Holdings, Quest Diagnostics Inc, SYNLAB International GmbH, and Myraid Genetics Inc are some of the leading companies operating in the Europe clinical reference laboratory market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 6.2% CAGR, Europe Clinical Reference Laboratory Market is Speculated to be Worth US$ 21,670.00 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe clinical reference laboratory market was valued at US$ 13,431.17 million in 2023 and is expected to reach US$ 21,670.00 million by 2031, registering a CAGR of 6.2% from 2023 to 2031. Strategic initiatives with reference laboratories and increasing number of clinical trials are among the critical factors attributed to drive the Europe clinical reference laboratory market growth.

Strategic initiatives by the laboratory service providers such as acquisition, alliance, and expansion with reference labs are among the most cost-effective ways to obtain the benefits of better patient care and cost efficiency. In 2024, Sweden and Denmark formed a public health partnership to build an EU reference laboratory (EURL) for antimicrobial resistance (AMR). The EURL will aid in infection preparedness and diagnostics. The European Commission (EC) has designated six EURLs for public health, including AMR, with the goal of bolstering EU defenses against significant cross-border threats. In 2024, the European Commission designated RIVM as the current EURL for vector-borne viral pathogens.

On the contrary, complications related to regulatory framework and adoption of continuous technological developments hamper the growth of Europe clinical reference laboratory market.

Based on service provider, the Europe clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held 60.4% market share in 2023, amassing US$ 8,117.25 million. It is projected to garner US$ 12,925.65 million by 2031 to register 6.1% CAGR during 2023-2031.

In terms of application, the Europe clinical reference laboratory medicine market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held 71.6% share of Europe clinical reference laboratory market in 2023, amassing US$ 9,616.34 million. It is anticipated to garner US$ 15,186.79 million by 2031 to expand at 5.9% CAGR during 2023-2031.

By country, the Europe clinical reference laboratory market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe clinical reference laboratory market in 2023. It was assessed at US$ 3,559.45 million in 2023 and is likely to hit US$ 5,820.81 million by 2031, registering a CAGR of 6.3% during 2023-2031.

Key players operating in the Europe clinical reference laboratory market are Sonic Healthcare Ltd, UNILABS, Laboratory Corp of America Holdings, Quest Diagnostics Inc, SYNLAB International GmbH, and Myraid Genetics Inc, among others.

In September 2020, Unilabs, the leading European diagnostic services provider, has completed the acquisition of Saltro, one of the largest and most innovative diagnostics companies in the Netherlands. The acquisition significantly expands Unilabs’ presence in the Netherlands, where its Medlon team currently provides laboratory diagnostics services in the eastern part of the country. With the addition of Saltro, Unilabs become one of the Netherlands’ largest and most complete diagnostics providers.

In April 2024, SYNLAB launched myEDIT-B is the first clinically validated test for the differential diagnosis between bipolar disorder and unipolar depression, signalling a paradigm shift in the identification of this mental health disorder and thus increasing the effectiveness of the treatment approach.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe clinical reference laboratory market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe clinical reference laboratory market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe clinical reference laboratory market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Europe Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Clinical Reference Laboratory Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Increasing Number of Clinical Trials
4.2 Market Restraints
4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
4.3 Market Opportunities
4.3.1 Strategic Initiatives with Reference Laboratories
4.4 Future Trends
4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
4.5 Impact of Drivers and Restraints:
5. Clinical Reference Laboratory Market – Europe Analysis
5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
5.2 Clinical Reference Market Forecast and Analysis
6. Europe Clinical Reference Laboratory Market Analysis – by Service Provider
6.1 Overview
6.2 Hospital-Based
6.2.1 Overview
6.2.2 Hospital-Based: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Standalone
6.3.1 Overview
6.3.2 Standalone: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Clinical Based
6.4.1 Overview
6.4.2 Clinical Based: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
7. Europe Clinical Reference Laboratory Market Analysis – by Application
7.1 Overview
7.2 Laboratory Medicine
7.2.1 Overview
7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Clinical Trials
7.3.1 Overview
7.3.2 Clinical Trials: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Clinical Reference Laboratory Market – Country Analysis
8.1 Europe Clinical Reference Laboratory Market Overview
8.1.1 Europe: Clinical Reference Laboratory Market Breakdown 2023 and 2031 (%) – by Country
8.1.1.1 Germany: Clinical Reference Laboratory Market – Overview
8.1.1.2 Germany: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Germany: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.2.2 Germany: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.3 United Kingdom: Clinical Reference Laboratory Market – Overview
8.1.1.4 United Kingdom: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 United Kingdom: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.4.2 United Kingdom: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.5 France: Clinical Reference Laboratory Market – Overview
8.1.1.6 France: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 France: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.6.2 France: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.7 Italy: Clinical Reference Laboratory Market – Overview
8.1.1.8 Italy: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.8.1 Italy: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.8.2 Italy: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.9 Spain: Clinical Reference Laboratory Market – Overview
8.1.1.10 Spain: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.10.1 Spain: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.10.2 Spain: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
8.1.1.11 Rest of Europe: Clinical Reference Laboratory Market – Overview
8.1.1.12 Rest of Europe: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.12.1 Rest of Europe: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
8.1.1.12.2 Rest of Europe: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
9. Clinical Reference Laboratory Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Clinical Reference Laboratory Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Sonic Healthcare Ltd
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 UNILABS
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Laboratory Corp of America Holdings
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Quest Diagnostics Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 SYNLAB International GmbH
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Myraid Genetics Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
11. Appendix
11.1 About The Research Team
11.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Clinical Reference Laboratory Market Segmentation
Table 2. Clinical Reference Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Germany: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 4. Germany: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. United Kingdom: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 6. United Kingdom: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 7. France: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 8. France: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 9. Italy: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 10. Italy: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 11. Spain: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 12. Spain: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 13. Rest of Europe: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Service Provider
Table 14. Rest of Europe: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 15. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
Table 16. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
Table 17. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Clinical Reference Laboratory Market Segmentation, by Country
Figure 2. Clinical Reference Laboratory Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
Figure 5. Clinical Reference Laboratory Market Share (%) – by Service Provider (2023 and 2031)
Figure 6. Hospital-Based: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standalone: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Clinical Based: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Clinical Reference Laboratory Market Share (%) – by Application (2023 and 2031)
Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Clinical Trials: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Europe: Clinical Reference Laboratory Market, by Key Country – Revenue (2023) (US$ Million)
Figure 14. Europe: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 15. Germany: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. United Kingdom: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. France: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Italy: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Spain: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Rest of Europe: Clinical Reference Laboratory Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Growth Strategies in the Clinical Reference Laboratory Market

The List of Companies – Europe Clinical Reference Laboratory Market

o Sonic Healthcare Ltd
o UNILABS
o Laboratory Corp of America Holdings
o Quest Diagnostics Inc
o SYNLAB International GmbH
o Myraid Genetics Inc

Reviews

There are no reviews yet.

Be the first to review “Europe Clinical Reference Laboratory Market Forecast to 2031”